Abstract
Monoclonal antibodies to certain cell surface constituents on lymphocytes, monocytes and macrophages have been administered to Lewis rats with developing, established or adoptively transferred arthritis, to determine any immunomodulatory properties. Anti-CD4 antibodies against helper T-lymphocytes produced a dose related inhibition of developing arthritis; high dose levels completely suppressed all symptoms of arthritis and these rats were resistant to further attempts to induce arthritis. Anti-Ia (MHCII) antibodies also inhibited arthritis in a dose related manner; anti-pan T antibodies delayed the onset of arthritis, but antibodies against CD8 and IL-2 receptor positive cells were without effect. Development of type II collagen-induced arthritis was also inhibited by anti-CD4 treatment. Established arthritis could be temporatily inhibited by anti-CD4 antibodies, but rebound of arthritis invariably occurred after stopping treatment, as is the case with cyclosporin A. Similar results with anti-CD4 antibodies were obtained during treatment of arthritis adoptively transferred by arthritogenic T-lymphocytes. From these experiments it is clear that CD4 positive T-lymphocytes have a major role in the induction of adjuvant arthritis and that interaction between CD4 and Ia bearing cells is important. The rebound of arthritis that occurred after withdrawal of anti-CD4 treatment during established disease infers that cells in addition to helper T-lymphocytes are involved in the chronicity of arthritis, but these remain to be elucidated. These findings are discussed in relation to results with monoclonal antibodies in other models of arthritis and human rheumatoid arthritis; the prospects for human therapy are also discussed.
Similar content being viewed by others
References
G. Janossy, O. Duke, L. W. Poulter, G. Panayi, M. Bofill and G. Goldstein,Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation. LancetII, 839–842 (1981).
J. D. Taurog, G. P. Sandberg and M. L. Mahowald,The cellular basis of adjuvant arthritis. II. Characterisation of the cells mediating passive transfer. Cell. Immunol.80, 198–204 (1983).
M. F. van den Broek, W. B. an den Berg and L. B. van de Putte,Monoclonal anti-Ia antibodies suppress the flare up reaction of antigen induced arthritis in mice. Clin. exp. Immunol.66, 320–330 (1986).
R. Holmdahl, L. Klareskog, K. Rubin, J. Bjork, G. Smedegard, R. Jonsson and M. Andersson,Role of T-lymphocytes in murine collagen induced arthritis. Agents and Actions19, 295–305 (1986).
O. Kohashi, Y. Kohashi, S. Kotani and A. Osawa,A new model of experimental arthritis induced by an aqueous form of synthetic adjuvant in immunodeficient rats (SHR and nude rats). Ryumachi21 Suppl., 149–155 (1981).
O. Kohashi, K. Aihara, A. Ozawa, S. Kotani and I. Azuma,New model of a synthetic adjuvant, N-acetyl muramyl-l-alanyl-d-isoglutamine-induced arthritis. Clinical and histologic studies in athymic nude and euthymic rats. Lab. Invest.47, 27–36 (1982).
K. Takagishi, N. Kaibara, T. Hotokobuchi, C. Arita, M. Morinaga and K. Aral,Effects of cyclosporin on collagen induced arthritis in mice. Ann. Rheum. Dis.45, 339–344 (1986).
D. E. Trentham, R. A. Dynesius and J. R. David,Passive transfer by cells of type II collagen-induced arthritis. J. Clin. Invest.62, 359–366 (1978).
J. Holoshitz, Y. Naparstek, A. Ben-Nun and I. R. Cohen,Lines of T-lymphocytes induce or vaccinate against autoimmune arthritis. Science219, 56–58 (1983).
R. Holmdahl, L. Klareskog, K. Rubin, E. Larsson and H. Wigzell,T-lymphocytes in collagen II-specific T-cell lines and clones. Characterisation of arthritogenic collagen II-specific T-cell lines and clones. Scand. J. Immunol.22, 295–306 (1985).
G. E. Ranges, S. Sriram and S. M. Cooper,Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L 3 T 4. J. exp. Med.162, 1105–1110 (1985).
J. T. Hom, L. D. Butler, P. E. Riedl and A. M. Bendele,The progression of the inflammation in established collagen-induced arthritis can be altered by treatment with immunological or pharmacological agents which inhibit T-cell activities. Eur. J. Immunol.18, 881–888 (1988).
P. H. Wooley, H. S. Luthra, W. P. Lafuse, A. Huse, J. M. Sturart and C. S. David,Type II collagen-induced arthritis in mice. III. Suppression of arthritis by using monoclonal and polyclonal anti-Ia antisera. J. Immunol.134, 2366–2374 (1985).
S. Banerjee, B.-Y. Wei, K. Hillman, H. S. Luthra and C. S. David,Immunosuppression of collagen-induced arthritis in mice with an anti-IL-2 receptor antibody. J. Immunol.141, 1150–1154 (1988).
P. Larsson, R. Holmdahl, L. Bencker and L. Klareskog,In vivo treatment with W3/13 (anti-pan T) but not OX8 (anti-suppressor/cytotoxic T) monoclonal antibodies impedes the development of adjuvant arthritis. Immunology56, 383–391 (1985).
K. M. Ferguson, H. Osawa, T. Diamantstein, A. L. Oronsky and S. S. Kerwer,Treatment with anti-interleukin 2 receptor antibody protects rats from passive but not active arthritis. Int. J. ImmunotherapyIV, 29–33 (1988).
M. E. J. Billingham, S. Fairchild, E. Griffin, L. Drayer and C. Hicks,Monoclonal antibody therapy for arthritis. InThe therapeutic control of inflammatory diseases. (ed. I. Otterness). Elsevier, New York (in press 1989).
C. Herzog, C. Walker, W. Pichler, A. Aeschlimann, P. Wassmer, H. Stockinger, W. Knapp, P. Rieber and W. Muller,Monoclonal anti-CD4 in arthritis. Lancetii, 1461–1462 (1987).
B. Kirkham, I. Chikanza, C. Pitzalis, G. H. Kingsley, R. Grahame, T. Gibson and G. Panayi,response to monoclonal CD7 antibody in rheumatoid arthritis. Lanceti, 588 (1988).
V. Kyle, R. J. Coughlan, H. Tiche, H. Waldmann and B. L. Hazleman,Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T-cells in rheumatoid arthritis. Ann. Rheum. Dis.48, 428–429 (1989).
J. Gauldie, C. Richards, D. Harnish, P. Lansdorp and H. Baumann,Interferon beta 2/B-cell stimulatory factor 2 shares identity with monocyte derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Soc. Natl. Acad. Sci. USA84, 7251–7155 (1987).
M. E. J. Billingham,Models of arthritis and the search for anti-arthritic drugs. Pharmac. Ther.21, 389–428 (1983).
S. Ayad, M. Z. Abedin, S. M. Grundy and J. B. Weiss,Isolation and characterisation of an unusual collagen from hyaline cartilage and intervertebral disc. Febs. Letters123, 195–199 (1981).
W. N. Erber, A. J. Pinching and D. W. Mason,Immunocytochemical detection of T and B populations in routine blood smears. Lanceti, 1042–1046 (1984).
W. A. Jefferies, J. R. Green and A. F. Williams,Authentic T helper CD4 (W3/25) antigen on rat peritoneal macrophages. J. exp. Med.162, 117–127 (1985).
V. H. Perry and S. Gordon,Modulation of CD4 antigen on macrophages and microglia in rat brain. J. exp. Med.166, 1138–1143 (1987).
F. C. Breedveld, R. Dynesius-Trentham, M. de Sousa and D. E. Trentham,Collagen arthritis in the rat is initiated by CD4+T cells and can be amplified by iron. Cell. Immunol.121, 1–12 (1989).
R. J. Benjamin and H. Waldmann,Induction of tolerance by monoclonal antibody therapy. Nature320, 449–451 (1986).
R. J. Benjamin, S. X. Qin, W. P. Wise, S. P. Cobbold and H. Waldmann,Mechanisms of monoclonal antibody-facilitated tolerance induction: a possible role for the CD4 (L 3 T 4)and CD11a (LFA-1) molecules in self-non-self discrimination. Eur. J. Immunol.18, 1079–1088 (1988).
L. Riechmann, M. Clark, H. Waldmann and G. Winter,Reshaping human antibodies for therapy. Nature332, 323–327 (1988).
H. Acha-Orbea, D. J. Mitchell, L. Timmermann, D. C. Wraith, G. S. Tausch, M. K. Waldor, S. S. Zamvil, H. O. McDevitt and L. Steinman,Limited heterogeneity of T-cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell54, 263–273 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Billingham, M.E.J., Hicks, C. & Carney, S. Monoclonal antibodies and arthritis. Agents and Actions 29, 77–87 (1990). https://doi.org/10.1007/BF01964727
Issue Date:
DOI: https://doi.org/10.1007/BF01964727